期刊文献+

心房颤动抗重构治疗进展

Progress of Anti-remodeling treatment in Atrial Fibrillation
下载PDF
导出
摘要 心房颤动的发生和维持机制复杂。目前的研究表明心房电重构和结构重构是心房颤动(AF)发生和持续的核心环节,主要包括电重构、结构重构和收缩功能重构三种形式。传统的复律、抗凝、控制心室率治疗已不足以满足患者的需要,与此相应,抗心房重构治疗代表了AF治疗的未来发展方向。目前在动物试验及临床研究中抗重构治疗已经取得了可喜的成果,本文综述了该领域研究的最新进展。 Machanism of occurrence and maintenance in atrial fibrillation is complex. It is well known that atrial remodeling which includes electrical remodeling, structural remodeling and contractile remodeling, are the central contributors to the development and self-perpetuating of atrial fibrillation. Traditional therapy including rhythm recovering, antieoagualtion, ventricular rate controling can not meet the requirement of patients. Accordingly, anti-atrial remodeling represents the therapeutic future of atrial fibrillation. At present the anti-atrial remodeling treatment has already obtained encouraging achievement in the animal experiment and the clinical research. Some recent advancements of this area is reviewed in this article.
作者 吴畏 许春萱
出处 《医学综述》 2006年第24期1508-1510,共3页 Medical Recapitulate
关键词 心房颤动 心房重构 治疗 Atrial fibrillation Atrial remodeling Therapy
  • 相关文献

参考文献20

  • 1Lai LP,Su MJ,Lin JL,et al.Down-regulation of L-type calcium channel and sareoplasmic reticular Ca ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor,calsequestrin and phospholamban[ J].J Am Coil of Cardio,1999,33(5):1231.
  • 2Yue Li,Feng J,Gaspo R,et al.Ionic remodeling underlying action potential changes in a canine model of Atrial fibrillation[ J].Circ Res,1997,81 (4):512-525.
  • 3Tieleman RG,De Langen C,Van Gelder IC,et al.Verapamil reducestachycardia-induced electrical remodeling of the atria[ J ] Circulation,1997,95(7):1945-1950.
  • 4Yu WC,Chen SA,Lee SH.Tachycardia-Induced Change of Atrial Refractory Period in Humans:Rate Dependency and Effects of Antiarrhythmic Drugs[J].Circulation 1998,97(23):2331-2337.
  • 5de Simone A,Stabile G,Vitale DF,et al.Pretreatment with verapamil inpatients with persistent or chronic atrial fibrillation who underwent electrical cardioversion[ J].J Am Coll Cardiol,1999,34(5):810-814.
  • 6Fareh S,Bénardeau A,Thibault B.The T-Type Ca2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs[ J].Circulation,1999,100(21):2191-2197.
  • 7Shinagawa K,Shiroshita-Takeshita A,Schram G,et al.Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium:insights into the mechanism of the superior efficacy of amiodarone[ J ].Circulation,2003,107(3):1440-1446.
  • 8Pratt CM,Singh SN,Al-Khalidi HR,et al.The efficacy of azimilide in the treatment of Atrial fibrillation in the presence of left ventricular systolic dysfunction[J].J Am Coll Cardiol,2004,43(6):1211-1216.
  • 9Nakashima H,Kumagai K,Urata H,et al.Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation[ J].Circulation,2000,101(6):2612-2617.
  • 10Brilla CG,Zhou G,Matsubara L,et al.Collagen metabolism in cultured adult rat cardiac fibroblasts:response to angiotensin Ⅱ and aldosterone[J].J Mol Cell Cardiol,1994,26(8):809-820.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部